In a filing, Immix Biopharma Inc revealed its CEO and Chairman Rachman Ilya M acquired Company’s shares for reported $4976.0 on Dec 10 ’25. In the deal valued at $6.67 per share,746 shares were bought. As a result of this transaction, Rachman Ilya M now holds 1,141,683 shares worth roughly $6.03 million.
Then, Morris Gabriel S bought 770 shares, generating $5,067 in total proceeds. Upon buying the shares at $6.58, the CFO now owns 291,429 shares.
Before that, Rachman Ilya M bought 2,500 shares. Immix Biopharma Inc shares valued at $5,050 were divested by the CEO and Chairman at a price of $2.02 per share. As a result of the transaction, Rachman Ilya M now holds 1,140,937 shares, worth roughly $6.02 million.
Price Performance Review of IMMX
On Tuesday, Immix Biopharma Inc [NASDAQ:IMMX] saw its stock fall -4.17% to $5.28. Over the last five days, the stock has lost -9.12%. Immix Biopharma Inc shares have risen nearly 151.43% since the year began. Nevertheless, the stocks have risen 140.00% over the past one year. While a 52-week high of $7.73 was reached on 12/12/25, a 52-week low of $1.34 was recorded on 04/08/25.
Levels Of Support And Resistance For IMMX Stock
The 24-hour chart illustrates a support level at 5.15, which if violated will result in even more drops to 5.02. On the upside, there is a resistance level at 5.52. A further resistance level may holdings at 5.76.
How much short interest is there in Immix Biopharma Inc?
A steep rise in short interest was recorded in Immix Biopharma Inc stocks on 2025-12-15, growing by 0.56 million shares to a total of 1.75 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 1.19 million shares. There was a rise of 32.1%, which implies that there is a positive sentiment for the stock.
